About

Thing
Cofactor will automatically discover the description of this topic and display it here.

Mentions

Intra-Cellular Therapies Inc said on Monday its lead drug to treat schizophrenia in adults has received approval from the U.S. Food and Drug Administration, sending its shares soaring 85%.

See also

See also: